Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An announcement from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) is now available.
ResMed Inc has announced a net decrease in the number of CHESS Depositary Interests (CDIs) issued over quoted securities for April 2025, with a reduction of 9,500,350 CDIs compared to the previous month. This change is attributed to net transfers of securities between CDIs and common stock on the NYSE. Additionally, there has been an increase in other securities due to stock options, restricted stock units, employee stock purchase plans, and share repurchases on the NYSE, reflecting the company’s ongoing financial and operational adjustments.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc is a company operating in the healthcare industry, primarily focusing on the development and manufacturing of equipment related to sleep disorders and respiratory care. The company is known for its innovative solutions in sleep apnea treatment and other respiratory conditions, serving a global market with its products and services.
YTD Price Performance: 1.55%
Average Trading Volume: 1,473,708
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$54.4B
See more data about RMD stock on TipRanks’ Stock Analysis page.